Skip to content

Dogwood Therapeutics DWTX Gain (loss) on disposal of assets

Gain (loss) on disposal of assets at other companies

Bioventus logo
BioventusBVS
$0+100%
Avanos Medical logo
Avanos MedicalAVNS
-$100K+50.0%

Segments

By segment

See full
Single Reportable-$2.73K

Other financials

Income statement

See full
Operating income-$5.1M-14.6%
Net income-$5.0M+54.4%
EPS (diluted)-$0.15+98.2%

Balance sheet

See full
Cash & equivalents$13.2M-24.6%
Total debt$144.9K-24.2%
Total equity$80.6M+1,038%
Total assets$95.2M-1.8%

Cash flow

See full
Operating cash flow-$4.6M+2.0%

Valuation

See full
Market cap$54.14M-57.6%
Enterprise value$41.06M-64.7%

Returns & leverage

See full
Return on equity-64.6%-29.8pp
Debt / equity0.0×
Current ratio5.9×-1.6×

Where this comes from

Reported directly by Dogwood Therapeutics in its filing.

Tagged under the XBRL concept us-gaap:GainLossOnSaleOfPropertyPlantEquipment.

The official record: Dogwood Therapeutics’s 10-K, filed March 18, 2026, on SEC EDGAR. View the filing →

Ask your AI about Dogwood Therapeutics's gain (loss) on disposal of assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Dogwood Therapeutics's gain (loss) on disposal of assets?
Dogwood Therapeutics (DWTX) reported gain (loss) on disposal of assets of -$682.75 in Q4 2025.
What does gain (loss) on disposal of assets mean?
Gains or losses recognized on the disposal of businesses, property, equipment, investments, or other assets at prices above or below their carrying value.